…Conclusion The TRED-HF2 trial enrolled a contemporary recovered DCM population with substantially higher baseline GDMT optimisation…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 433 of 2459…old of the Fontan adults compared to the healthy adults and the TOF adults…
…ous coronary intervention with drug-eluting stents (DES-PCI) in multivessel coronary artery disease remains controversial, with conflicting evidence from observati…
…Introduction Beta-blockers are routinely prescribed following myocardial infarction (MI) d…
…-6. Furthermore, it has been shown previously by our group that metformin can increase FN3K expression. It is anticipated that continuous…
…nt DM which improved 10-year DM prediction beyond the Leicester Diabetes Risk Score (AUC 0.736 vs 0.805, p<0.001) and were associated wi…
… during recovery.Sensitivity analysis excluding participants on aspirin or oral anticoagulation were similar.Conclusion Endothelial act…
…Objective Inflammatory bowel disease (IBD) is increasingly recognised in the Middle East, but limite…
…gh burden of complications, including heart failure, stroke and kidney disease. Community-centred approaches using community health workers (C…
…y cells, in both single-agent and in combination treatment with atezolizumab. This was accompanied by transient elevation of granulocyte-mac…
…used on original studies reporting safety outcomes following IM ketamine administration in acute care settings.Results Three retrospecti…
… cruciate ligament (ACL)) outcomes were reported weekly. Weekly Prep-to-Play use (yes/no) was defined as using ≥75% of programme elements, ≥…